Because many people in the research community are facing considerable challenges trying to juggle various responsibilities during the COVID-19 outbreak, NIGMS will accommodate late application submissions for due dates in May 2020 for all NIGMS-specific FOAs (see NOT-GM-20-029). For applications submitted through June 30, 2020, institutions do not need to request advance permission or provide a cover letter to justify a late submission to these FOAs. Applications with due dates prior to May 25 should use FORMS E and those with due dates on or after May 25 should use FORMS F, regardless of the date of submission.
CURRENT NIGMS FUNDING ANNOUNCEMENTS IMPACTED BY THIS POLICY:
Title
FOA Number
Applicable Application Due Date
Applicable Forms Package
Maximizing Investigators’ Research Award (R35 – Clinical Trial Optional)
5/18/2020
FORMS E
IDeA Networks of Biomedical Research Excellence (INBRE) (P20 – Clinical Trial Optional)
5/20/2020
FORMS E
Maximizing Access to Research Careers (T34)
5/21/2020
FORMS E
Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34)
5/21/2020
FORMS E
Graduate Research Training Initiative for Student Enhancement (G-RISE) (T32)
5/21/2020
FORMS E
National Institute of General Medical Sciences Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Institutional Research Training Grant (T32)
5/25/2020
FORMS F
Medical Scientist Training Program (T32)
5/25/2020
FORMS F
Support of Competitive Research (SCORE) Research Continuance Award (SC3 – Clinical Trial Not Allowed)
5/25/2020
FORMS F
Support of Competitive Research (SCORE) Pilot Project Award (SC2 – Clinical Trial Not Allowed)
5/25/2020
FORMS F
Support of Competitive Research (SCORE) Research Advancement Award (SC1 – Clinical Trial Not Allowed)
5/25/2020
FORMS F
Biomedical Technology Development and Dissemination Center (RM1 – Clinical Trial Not Allowed)
5/26/2020
FORMS F
Collaborative Program Grant for Multidisciplinary Teams (RM1 – Clinical Trial Optional)
5/27/2020
FORMS F
Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III – Transitional Centers (P30 – Clinical Trial Optional)
5/28/2020
FORMS F
NIH’s late application submission policy for institutions closed due to the effects of COVID-19 (NOT-OD-20-082) still applies to these FOAs for institutions that aren’t able to submit by June 30 and will be considered on a case-by-case basis. As much as NIGMS would like to extend flexibility further, this rapidly evolving situation creates multiple challenges for conducting both initial peer review and advisory council review by January 2021. Therefore, applicants should assume that late applications submitted after June 30, 2020, may not be reviewed for the current council round.
Please direct all inquiries to NIGMS_DEA_Mailbox@nigms.nih.gov.
Based on the information above, applications with due dates prior to May 25 should use Forms E. Since Forms E expire on June 25, does this mean that the application has to be submitted by June 24? Or, can/should an application with a due date prior to May 25 use Forms F if submitting after June 24 but prior to June 30? We don’t want the application rejected for a forms issue.
You can use Forms F for all FOAs after June 24.